Filing Details

Accession Number:
0000950170-25-013831
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-04 17:53:11
Reporting Period:
2025-02-03
Accepted Time:
2025-02-04 17:53:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1527599 Synlogic Inc. SYBX Pharmaceutical Preparations (2834) 261824804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2015112 Beth Mary Dooley C/O Synlogic, Inc.
Po Box 30
Winchester MA 01890
See Remarks Below No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-02-03 2,107 $1.33 13,045 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the reporting person on February 3, 2025 to cover the tax liability in connection with the vesting of a restricted stock award, vesting on January 31, 2025, that was granted on January 2, 2024.